Literature DB >> 3207614

Inhibition of 5 alpha-reductase activity in human skin by zinc and azelaic acid.

D Stamatiadis1, M C Bulteau-Portois, I Mowszowicz.   

Abstract

The effects of zinc sulphate and azelaic acid on 5 alpha-reductase activity in human skin were studied using an in vitro assay with 1,2[3H]-testosterone as substrate. When added at concentrations of 3 or 9 mmol/l, zinc was a potent inhibitor of 5 alpha-reductase activity. At high concentrations, zinc could completely inhibit the enzyme activity. Azelaic acid was also a potent inhibitor of 5 alpha-reductase; inhibition was detectable at concentrations as low as 0.2 mmol/l and was complete at 3 mmol/l. An additive effect of the two inhibitors was observed. Vitamin B6 potentiated the inhibitory effect of zinc, but not of azelaic acid, suggesting that two different mechanisms are involved. When the three substances were added together at very low concentrations which had been shown to be ineffective alone, 90% inhibition of 5 alpha-reductase activity was obtained. If this inhibition is confirmed in vivo, zinc sulphate combined with azelaic acid could be an effective agent in the treatment of androgen related pathology of human skin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3207614     DOI: 10.1111/j.1365-2133.1988.tb03474.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  10 in total

1.  A double-blind controlled evaluation of the sebosuppressive activity of topical erythromycin-zinc complex.

Authors:  C Piérard-Franchimont; V Goffin; J N Visser; H Jacoby; G E Piérard
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

Review 2.  Azelaic acid. A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders.

Authors:  A Fitton; K L Goa
Journal:  Drugs       Date:  1991-05       Impact factor: 9.546

3.  Azelaic acid stimulates catalase activation and promotes hair growth through upregulation of Gli1 and Gli2 mRNA and Shh protein.

Authors:  Elham Amirfakhryan; Behzad Davarnia; Farhad Jeddi; Nowruz Najafzadeh
Journal:  Avicenna J Phytomed       Date:  2020 Sep-Oct

4.  Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne.

Authors:  Haibo Liu; Haiyan Yu; Jun Xia; Ling Liu; Guan J Liu; Hong Sang; Frank Peinemann
Journal:  Cochrane Database Syst Rev       Date:  2020-05-01

5.  BCL-2 and Bax Expression in Skin Flaps Treated with Finasteride or Azelaic Acid.

Authors:  Seyyed Abdulmajid Ayatollahi; Marjan Ajami; Hamed Reyhanfard; Yasin Asadi; Mansour Nassiri-Kashani; Mehdi Rashighi Firoozabadi; Sayed Hossein Davoodi; Esmaeil Habibi; Hamidreza Pazoki-Toroudi
Journal:  Iran J Pharm Res       Date:  2012       Impact factor: 1.696

6.  ADT-G as a promising biomarker for peripheral hyperandrogenism in adult female acne.

Authors:  Marco Rocha; Karina H M Cardozo; Valdemir M Carvalho; Edieia Bagatin
Journal:  Dermatoendocrinol       Date:  2017-10-13

7.  Combined Cutaneous Therapy Using Biocompatible Metal-Organic Frameworks.

Authors:  Seyed Dariush Taherzade; Sara Rojas; Janet Soleimannejad; Patricia Horcajada
Journal:  Nanomaterials (Basel)       Date:  2020-11-25       Impact factor: 5.076

8.  Application of HPLC with ELSD detection for the assessment of azelaic acid impurities in liposomal formulation.

Authors:  Stanislaw Han; Katarzyna Karlowicz-Bodalska; Dorota Szura; Lukasz Ozimek; Witold Musial
Journal:  ScientificWorldJournal       Date:  2013-10-08

9.  Identification of unknown impurity of azelaic acid in liposomal formulation assessed by HPLC-ELSD, GC-FID, and GC-MS.

Authors:  Stanisław Han; Katarzyna Karłowicz-Bodalska; Piotr Potaczek; Adam Wójcik; Lukasz Ozimek; Dorota Szura; Witold Musiał
Journal:  AAPS PharmSciTech       Date:  2013-10-29       Impact factor: 3.246

10.  Benign prostatic hyperplasia complicated with T1DM can be alleviated by treadmill exercise-evidences revealed by the rat model.

Authors:  Kuan-Chou Chen; Shian-Ying Sung; Yi-Ting Lin; Chiu-Lan Hsieh; Kun-Hung Shen; Chiung-Chi Peng; Robert Y Peng
Journal:  BMC Urol       Date:  2015-11-17       Impact factor: 2.264

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.